Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 118Carboplatin 101Paclitaxel 62Cisplatin 56Gemcitabine 55Pemetrexed 52Bevacizumab 49Docetaxel 44Fluorouracil 39Oxaliplatin 37Dexamethasone 34130-nm albumin-bound paclitaxel 33atezolizumab 32Leucovorin 32Cetuximab 31durvalumab 26Nivolumab 25Capecitabine 25Rituximab 24Prednisone 24Fulvestrant 23Cyclophosphamide 23Lenalidomide 22enzalutamide 21venetoclax 20Irinotecan 19Letrozole 18pomalidomide 16apalutamide 16daratumumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Minocycline × 30 days × Clear all
NCT06120140 2026-06-05

COCOON

Janssen Research & Development, LLC

Phase 2 Active not recruiting
305 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡